Article metrics

Download PDFPDF
An Open-Label Phase 2 Study of Twice-Weekly Bortezomib and Intermittent Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer Failing Platinum-Containing Regimens

 

Online download statistics by month:

Online download statistics by month: January 2019 to November 2021

AbstractFullPdf
Jan 2019400
Feb 2019600
Mar 20191400
Apr 20192800
May 20192602
Jun 20192000
Jul 20191901
Aug 20192200
Sep 20192200
Oct 20191401
Nov 20193000
Dec 20192302
Jan 20203101
Feb 20203001
Mar 2020600
Apr 20201201
May 20202400
Jun 20201000
Jul 20202000
Aug 20201800
Sep 20202000
Oct 20201700
Nov 20201400
Dec 20201400
Jan 20211200
Feb 20218200
Mar 20212800
Apr 20211400
May 20211800
Sep 2021002
Oct 20212000
Nov 20211200
Total630011